T he recent increase in extended-spectrum -lactamase (ESBL) producers among community Escherichia coli isolates has been of great concern worldwide. In previous studies, recent contact with the health care system was identified as a major risk factor for community onset ESBL-producing E. coli (ESBL-EC) infections (1-3). However, ESBL-EC is causing increasing numbers of community onset infections, especially urinary tract infections (UTIs), among patients without health care-associated (HCA) risk factors, i.e., those with community-associated (CA) UTIs (3, 4). These findings emphasize the need for new empirical antibiotic strategies for managing UTIs in the community. However, only a few studies have examined what predispose patients with no discernible HCA risk factors to develop ESBL-EC UTIs and how these patients differ clinically from those with non-ESBL-EC UTIs. Most previous studies have focused on bloodstream infections, which represent the most serious form of E. coli infections, and combined CA and HCA infections in their analyses without analyzing them separately (5, 6). Because HCA infections often resemble hospital-acquired infections and tend to have more severe symptoms (7-10), the impact of ESBL production on treatment outcomes might be overestimated in CA infections, which might potentially lead to overtreatment for less serious infections. Among CA-UTIs, CA acute pyelonephritis (APN) caused by ESBL-EC has rarely been studied, even though APN can pose a dilemma for antibiotic selection because it ranges from clinically benign uncomplicated episodes to severe septic shock. Therefore, we investigated the risk factors for ESBL-EC acquisition to help identify patients likely to have CA-APN caused by ESBL-EC, and we clarified the impact of ESBL production on the treatment outcomes of CA-APN caused by E. coli by comparing patients with CA-APN caused by ESBL-EC to those with CA-APN caused by non-ESBL-EC.
MATERIALS AND METHODSStudy design and patients. We conducted a case-control study from a retrospective cohort of adult patients with community onset APN caused by E. coli who were treated at Daejeon St. Mary's Hospital between January 2007 and December 2013. Daejeon St. Mary's Hospital is a 600-bed secondary-care community hospital serving Daejeon city and the surrounding areas, with a population of approximately 1.5 million people. Patients were included in this retrospective cohort if they were Ͼ15 years of age and were diagnosed with community onset APN caused by E. coli. This cohort was further divided into two subcohorts, CA-APN and HCA-APN. The case patients were those with CA-APN caused by ESBL-EC (CA-ESBL group), and for patients with multiple episodes, only the first episode was included in the analysis. The control patients were those with 2015. Impact of extended-spectrum -lactamase production on treatment outcomes of acute pyelonephritis caused by Escherichia coli in patients without health care-associated risk factors.